AGEN vs ZTS · P/E 1.6, rev $68.3M vs P/E 25, rev $2.47B
Agenus Inc (AGEN) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the AGEN and ZTS stock pages for the full models.
Not investment advice.